Searched for
BHARAT BIOTECH INDIA LTD
Info Edge says it invested Rs 1,003 crore on AI, deeptech startups since 2020Info Edge, the parent of Naukri, has significantly boosted its AI and deeptech investments, pouring Rs 1,003 crore into 54 startups since 2...- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities ended higher on Tuesday, supported by easing geopolitical tensions and softer crude prices. A sharp drop in India VIX boost...
- Shastra VC launches $100 million fund to back deeptech, AI startupsThe Bengaluru-based firm said the new vehicle will invest between $500,000 and $3 million in IP-led firms across these sectors. The launch ...
- Bharat Biotech, Biofabri in tech transfer deal for TB vaccineMTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...
- Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines production, supplyBharat Biotech on Tuesday said it has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Instit...
- Bharat Biotech seeks nod for intranasal Covid vaccineAccording to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...
- Bharat Biotech expects regulator's nod for intranasal COVID-19 vaccine in August"We will be applying for licenses and (they) should come. If everything goes well, we know by next month (August). You (people) would rathe...
- Panel recommends Covaxin for Children aged 6-12 yearsIn a meeting held on Thursday, the SEC reviewed Bharat Biotech's application seeking grant of marketing authorisation for additional indica...
- Bharat Biotech proud of contribution to historic landmark: Dr Krishna Ella on COVID vaccination coverage crossing 100 cr markTerming the achievement as a "true success story of Atmanirbharta", he said that it was a unified effort of the government, vaccine manufac...
- India's Bharat Biotech scouts international COVID-19 vaccine partnersCOVAXIN, the company's home-grown COVID-19 vaccine approved for emergency use in India, is one of two shots driving the country's massive v...
- New Delhi now engages in quiet Covaxin diplomacyUnlike China, India is not pursuing an aggressive policy to get Covaxin approved but rather a quiet diplomacy, advising Bharat Biotech on n...
- COVAXIN: News reports on submitting Phase-3 data to WHO is incorrect, says Bharat BiotechBharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use...
- Bharat Biotech inks pact with Precisa Medicamentos for Covaxin supplies to BrazilThe Brazilian Ambassador to India Andr Aranha Corra do Lago expressed keen interest on behalf of his government towards procuring the vacci...
- Rajasthan CM Ashok Gehlot seeks PM Modi's intervention in COVID-19 vaccine rowTaking to Twitter, he said the "bayanbaazi" (remarks) between the Serum Institute and Bharat Biotech after the approval of their vaccines b...
- Timeline: How India's coronavirus vaccine got approved by drugs expertsCOVAXIN has been developed by Bharat Biotech, a company based in Hyderabad, with backing from the state-run Indian Council of Medical Resea...
- Bharat Biotech's top brass calls on vice presidentThe indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment faci...
- Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of CovaxinBharat Biotech has signed up 13,000 volunteers for the Phase 3 trial, backed by India's government medical research body, and is progressin...
- Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...
Load More
